Private Advisor Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100
Closed -$2.4K 2646
2025
Q2
$2.4K Buy
+100
New +$77.7K ﹤0.01% 2448
2024
Q1
Sell
-300
Closed -$1.2K 2382
2023
Q4
$1.2K Hold
300
﹤0.01% 2234
2023
Q3
$2.7K Buy
+300
New +$155K ﹤0.01% 2226

Other funds holding LLY

Private Advisor Group's LLY Position: Q1 2026 in Review

Private Advisor Group reduced its Eli Lilly (LLY) stake by 0.73% in Q1 2026, selling an estimated $643K and leaving 86,496 shares worth $79.6M. The position accounts for 0.37% of the portfolio, ranked #43.

Private Advisor Group first reported a position in LLY in Q4 2013 and has held it in 50 quarters since. The position peaked at $93.6M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Private Advisor Group held 86,496 shares of Eli Lilly worth $79.6M as of Q1 2026.
  • Private Advisor Group sold 634 Eli Lilly shares in Q1 2026, an estimated $643K.
  • Eli Lilly made up 0.37% of Private Advisor Group's portfolio in Q1 2026, its #43 holding.
  • Private Advisor Group first reported a position in Eli Lilly in Q4 2013 and has held it in 50 quarters since.
  • Private Advisor Group's Eli Lilly position peaked at $93.6M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.